Characterization and representation of substandard drugs in the area of pharmacovigilance scope: a narrative review

Authors

DOI:

https://doi.org/10.22239/2317-269x.01922

Keywords:

Pharmacovigilance, Notification, Quality Control, Pharmaceutical Preparations

Abstract

Introduction: Substandard drugs (SD) present great relevance in the area of pharmacovigilance and should be investigated and monitored as they can lead to several clinical outcomes. Objective: To discuss the characteristics of SD in the area of  pharmacovigilance through a narrative review. Method: A comprehensive search was performed on databases using the descriptors “pharmacovigilance”, “technical complaints (TC)”, “SD” and “notification systems” including studies directly concerning the subject conducted in Brazil and published between 2005 and 2020. Results: SD issues might be associated with drug product alterations, content and integrity of the package and labeling. Among the 18 selected studies (14 articles, two book chapters and two dissertations) regarding SD notifications reported as drug TC, two exclusively evaluated drug  TC notifications (100.0%), while the rest showed that this type of notification represented 0.6% to 70.0% of the total of notifications made in national health establishments. The main SD issues found were:  alterations on the product aspect; absence/reduction in the amount of drug product; and, package problems. Conclusions: Notifications involving SD issues are considered an excellent quality indicator for the drugs available in the market, which contributes to suppliers’ qualification and provision of consistent products for the population.

Downloads

Download data is not yet available.

Author Biography

  • Jaqueline Kalleian Eserian, Centro de Medicamentos, Cosméticos e Saneantes, Instituto Adolfo Lutz, São Paulo, SP, Brasil

    Graduada em Farmácia - Faculdades Oswaldo Cruz (2008). Possui mestrado (2011) e doutorado (2018) em Ciências pelo Departamento de Psicobiologia da Universidade Federal de São Paulo (Unifesp). Atualmente é Pesquisador Científico do Instituto Adolfo Lutz (Centro de Medicamentos, Cosméticos e Saneantes). Atua também como docente do Centro de Formação de Recursos Humanos para o SUS/SP (Cefor/SP) no Curso de Especialização em Vigilância Laboratorial em Saúde Pública (Vigilância Sanitária e Ambiental). É editora associada do periódico Infarma - Ciências Farmacêuticas. Possui experiência nas áreas de farmácia e saúde pública, com ênfase em medicamentos, atuando principalmente nos seguintes temas: substâncias psicoativas, controle de qualidade físico-químico e terapêutica medicamentosa.

Published

2022-05-31

Issue

Section

Revision article

How to Cite

Characterization and representation of substandard drugs in the area of pharmacovigilance scope: a narrative review. (2022). Health Surveillance under Debate: Society, Science & Technology , 10(2), 93-102. https://doi.org/10.22239/2317-269x.01922

Similar Articles

1-10 of 347

You may also start an advanced similarity search for this article.